A lifespan view of anxiety disorders.

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Dialogues in clinical neuroscience 01/2011; 13(4):381-99.
Source: PubMed

ABSTRACT Neurodevelopmental changes over the lifespan, from childhood through adulthood into old age, have important implications for the onset, presentation, course, and treatment of anxiety disorders. This article presents data on anxiety disorders as they appear in older adults, as compared with earlier in life. In this article, we focus on aging-related changes in the epidemiology, presentation, and treatment of anxiety disorders. Also, this article describes some of the gaps and limitations in our understanding and suggests research directions that may elucidate the mechanisms of anxiety disorder development later in life. Finally we describe optimal management of anxiety disorders across the lifespan, in "eight simple steps" for practitioners.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Anxiety and related disorders include generalised anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder and phobic disorders (intense fear of an object or situation). These disorders share the psychological and physical symptoms of anxiety, but each disorder has its own set of characteristic symptoms. Anxiety disorders can be difficult to recognise, particularly in older people (those aged over 65 years). Older people tend to be more reluctant to discuss mental health issues and there is the perception that older people are generally more worried than younger adults. It is estimated that between 3 and 14 out of every 100 older people have an anxiety disorder. Despite treatment, some people will continue to have symptoms of anxiety. People are generally considered to be 'resistant' or 'refractory' to treatment if they have an inadequate response or do not respond to their first treatment. Older adults with an anxiety disorder find it difficult to manage their day-to-day lives and are at an increased risk of comorbid depression, falls, physical and functional disability, and loneliness.
    Health technology assessment (Winchester, England) 08/2014; 18(50):1-60. DOI:10.3310/hta18500 · 5.12 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mindfulness-based stress reduction (MBSR) has the potential to reduce worry and improve cognitive functioning. In this treatment development project, we examined MBSR in older adults with worry symptoms and co-occurring cognitive dysfunction. We examined (i) acceptability of MBSR, (ii) whether MBSR needs to be lengthened providing more repetition, (iii) MBSR's benefits for worry reduction and cognitive improvements, and (iv) continued use of MBSR techniques during follow-up. Two sites (St. Louis and San Diego) enrolled individuals aged 65 years or older with significant anxiety-related distress plus subjective cognitive dysfunction, into traditional 8-session MBSR groups and 12-session groups that had the same content but more repetition of topics and techniques. We examined measures of mindfulness, worry, and a neuropsychological battery focused on memory and executive function before and after the MBSR program, and we followed up participants for 6 months after the completion of MBSR regarding their continued use of its techniques. Participants (N = 34) showed improvements in worry severity, increases in mindfulness, and improvements in memory as measured by paragraph learning and recall after a delay, all with a large effect size. Most participants continued to use MBSR techniques for 6 months post-instruction and found them helpful in stressful situations. There was no evidence that the extended 12-week MBSR produced superior cognitive or clinical outcomes, greater satisfaction, or greater continuation of MBSR techniques than 8-week MBSR. These preliminary findings are promising for the further testing and use of MBSR in older adults suffering from clinical worry symptoms and co-occurring cognitive dysfunction. These are common problems in a broad range of older adults, many of whom have anxiety and mood disorders; therefore, stress reduction intervention for them may have great public health value. Copyright © 2014 John Wiley & Sons, Ltd.
    International Journal of Geriatric Psychiatry 10/2014; 29(10). DOI:10.1002/gps.4086 · 3.09 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Previous studies consistently showed significant associations between depression and anemia, or depression and low cholesterol level.However, almost all studies in this field evaluated effects of only one of these blood components on depression severity. Few studies evaluated effects of either anemia or low cholesterol on anxiety severity. Methods: In the present retrospective study we analyzed data from the database of Moscow Research and Clinical Center for Neuropsychiatry. Data of 1937 in-patients with non-psychotic psychiatric disorders were included into the analysis. Patients were evaluated using Beck Depression Inventory (BDI),Hamilton Depression Rating Scale (HDRS), and Spielberger State-Trait Anxiety Scaleat admission and after 3 – 5 weeks of treatment. Hemoglobin and total cholesterol measurements at 08:00 a.m. within 24 hours of hospital admission were analyzed. Results: Anemia was significantly associated with higher anxiety level at admission and lower improvement of anxiety at discharge in females independently of cholesterol level. Negative effects of anemia on depression severity was found only in females with cholesterol > 5 mmol/L. Contrary to our expectations, subgroup of females with cholesterol ≤ 5 mmol/L showed the opposite trend, i.e. anemia was associated with lower HDRS at both assessments in comparison with controls. Moreover, in young females (age < 40 years; n=250) hemoglobin positively correlated with BDI, HDRS and state anxiety scores. Only 3.6% of males showed anemia, so the data were inconsistent. Low cholesterol was nearly significantly associated with more severe anxiety in three patient subgroups: females with normal hemoglobin, females with anemia, and males. Contrary to our expectations, decreased cholesterol was associated with better improvement of HDRS in males. Conclusion: Anemia and cholesterol level are independently associated with the severity of negative affectivity. However, the direction of these associations may differ according to the age and, perhaps, length of the hyperactivation of stress response systems.


Available from